MeiraGTx Holdings plc financial data

Symbol
MGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
450 East 29 Th Street, 15 Th Floor, New York, New York
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 222 % +25.9%
Debt-to-equity 155 % +6.72%
Return On Equity -62.4 % +42.9%
Return On Assets -24.4 % +45%
Operating Margin -2.01 K % -923%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.2 M shares +32%
Common Stock, Shares, Outstanding 64.3 M shares +32.6%
Entity Public Float 260 M USD +7.12%
Common Stock, Value, Issued 2 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 64.1 M shares +31.7%
Weighted Average Number of Shares Outstanding, Diluted 64.1 M shares +31.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 697 K USD -79.1%
Revenue from Contract with Customer, Excluding Assessed Tax 6.69 M USD -84.2%
Research and Development Expense 116 M USD +36.3%
General and Administrative Expense 47.7 M USD -0.8%
Operating Income (Loss) -152 M USD -27.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -74.1 M USD +42.5%
Earnings Per Share, Basic -1.19 USD/shares +57.3%
Earnings Per Share, Diluted -1.19 USD/shares +57.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 119 M USD +73.3%
Accounts Receivable, after Allowance for Credit Loss, Current 10.9 M USD
Other Assets, Current 932 K USD -40.3%
Assets, Current 149 M USD +22.9%
Other Long-term Investments 1.5 M USD 0%
Property, Plant and Equipment, Net 111 M USD -1.04%
Operating Lease, Right-of-Use Asset 14.8 M USD -23.6%
Intangible Assets, Net (Excluding Goodwill) 1.04 M USD -19.8%
Other Assets, Noncurrent 1.14 M USD -20.3%
Assets 309 M USD +7.32%
Accounts Payable, Current 21.2 M USD -28.7%
Accrued Liabilities, Current 17.4 M USD -44.1%
Liabilities, Current 47.5 M USD -41.4%
Deferred Income Tax Liabilities, Net 184 K USD +7.6%
Operating Lease, Liability, Noncurrent 11.8 M USD -28.3%
Liabilities 188 M USD -5.26%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.13 M USD -185%
Retained Earnings (Accumulated Deficit) -575 M USD -14.8%
Stockholders' Equity Attributable to Parent 122 M USD +34.9%
Liabilities and Equity 309 M USD +7.32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.7 M USD +1.74%
Net Cash Provided by (Used in) Financing Activities -1.27 M USD -3.17%
Net Cash Provided by (Used in) Investing Activities 27.3 M USD
Common Stock, Shares Authorized 1.29 B shares 0%
Common Stock, Shares, Issued 64.3 M shares +32.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 120 M USD +74.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.95 M USD +87.9%
Deferred Tax Assets, Valuation Allowance 126 M USD +8.31%
Deferred Tax Assets, Gross 131 M USD +4.83%
Operating Lease, Liability 16 M USD -21.9%
Payments to Acquire Property, Plant, and Equipment 1.68 M USD -80.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -80.9 M USD +35%
Lessee, Operating Lease, Liability, to be Paid 18.8 M USD -22.5%
Property, Plant and Equipment, Gross 149 M USD +15.1%
Operating Lease, Liability, Current 4.19 M USD +4.23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.5 M USD +3.99%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.12 M USD +0.59%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.83 M USD -25.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.59 M USD +6.6%
Deferred Tax Assets, Operating Loss Carryforwards 70.7 M USD -4.98%
Unrecognized Tax Benefits 2.03 M USD +117%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.61 M USD -67.7%
Operating Lease, Payments 5.7 M USD +5.54%
Additional Paid in Capital 700 M USD +19.2%
Depreciation, Depletion and Amortization 3.28 M USD +5.92%
Share-based Payment Arrangement, Expense 28.2 M USD +2.79%
Interest Expense 13.4 M USD +69.4%